Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9380705 | Journal of Affective Disorders | 2005 | 5 Pages |
Abstract
Patients given active medication during the luteal phase demonstrate reductions in DRSP total scores into the first few days of menses regardless of whether active treatment was continuous throughout the menstrual cycle or was discontinued at the onset of menses. This analysis finds no support for discontinuation symptoms following abrupt cessation of sertraline after 2 weeks of treatment for two cycles.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Kimberly A. Yonkers, Teri Pearlstein, Rana Fayyad, John A. Gillespie,